Literature DB >> 33403168

A Case of Endobronchial Aspergilloma Coexisting With Lung Adenocarcinoma.

Halim El Hage1, Leon Fagel2.   

Abstract

Aspergillus species can cause a variety of lung diseases. Endobronchial aspergilloma is a rare clinical entity rarely encountered and often not included in the classification of Aspergillus lung diseases.  An 82-year-old woman presented to the outpatient setting with wheezing, shortness of breath, and productive cough. CT of the chest showed the presence of airway enlargement in a finger in glove pattern in the right upper lobe suggestive of allergic bronchopulmonary aspergillosis. Despite adequate treatment the abnormality persisted on repeat imaging. Bronchoscopy with biopsies eventually revealed the presence of hyphal elements suggestive of Aspergillus and poorly differentiated adenocarcinoma. Endobronchial aspergilloma is rare and not included in the classification of Aspergillus lung diseases. It is thought to result from airway colonization by Aspergillus species. Occasionally it can obscure an underlying lung carcinoma and thus delay the diagnosis. Diagnosis is made by pathological examination of biopsy specimens. Optimal treatment is not well established.
Copyright © 2020, El Hage et al.

Entities:  

Keywords:  aspergilloma; bronchoscopy; lung adenocarcinoma

Year:  2020        PMID: 33403168      PMCID: PMC7773290          DOI: 10.7759/cureus.11736

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  8 in total

Review 1.  Two cases of endobronchial carcinoid masked by superimposed aspergillosis: a review of the literature of primary lung cancers associated with Aspergillus.

Authors:  John Robert Nilsson; Carlos S Restrepo; Jaishree Jagirdar
Journal:  Ann Diagn Pathol       Date:  2011-11-10       Impact factor: 2.090

Review 2.  The clinical spectrum of pulmonary aspergillosis.

Authors:  Ayman O Soubani; Pranatharthi H Chandrasekar
Journal:  Chest       Date:  2002-06       Impact factor: 9.410

Review 3.  Pulmonary aspergilloma: from classification to management.

Authors:  Hicham Harmouchi; Rabiou Sani; Ibrahim Issoufou; Marouane Lakranbi; Yassine Ouadnouni; Mohamed Smahi
Journal:  Asian Cardiovasc Thorac Ann       Date:  2019-12-04

Review 4.  Allergic bronchopulmonary aspergillosis.

Authors:  Ritesh Agarwal
Journal:  Chest       Date:  2009-03       Impact factor: 9.410

Review 5.  Pulmonary aspergillosis: a clinical update.

Authors:  O S Zmeili; A O Soubani
Journal:  QJM       Date:  2007-06

Review 6.  Endobronchial aspergilloma: report of 10 cases and literature review.

Authors:  Jeong Eun Ma; Eun Young Yun; You Eun Kim; Gi Dong Lee; Yu Ji Cho; Yi Yeong Jeong; Kyoung-Nyeo Jeon; In Seok Jang; Ho Cheol Kim; Jong Deok Lee; Young Sil Hwang
Journal:  Yonsei Med J       Date:  2011-09       Impact factor: 2.759

7.  Invasive Aspergillosis in a Patient with Stage III (or 3a or 3b) Non-Small-Cell Lung Cancer Treated with Durvalumab.

Authors:  Ashish Gupta; Aung Tun; Katy Ticona; Aam Baqui; Elizabeth Guevara
Journal:  Case Rep Oncol Med       Date:  2019-08-27

8.  Endobronchial aspergilloma: A case report and literature review.

Authors:  Dongdong Huang; Bing Li; Haiqing Chu; Zhemin Zhang; Qiuhong Sun; Lan Zhao; Liyun Xu; Li Shen; Tao Gui; Huikang Xie; Jun Zhang
Journal:  Exp Ther Med       Date:  2017-06-01       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.